CytomX Therapeutics Inc (CTMX)

13.50
0.11 0.82
NASDAQ : Health Care
Prev Close 13.39
Open 13.49
Day Low/High 13.27 / 13.76
52 Wk Low/High 9.01 / 24.68
Volume 135.65K
Avg Volume 232.80K
Exchange NASDAQ
Shares Outstanding 36.75M
Market Cap 488.04M
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Commit To Buy CytomX Therapeutics At $12.50, Earn 17.9% Annualized Using Options

Investors considering a purchase of CytomX Therapeutics Inc shares, but tentative about paying the going market price of $13.51/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $12.50 strike, which has a bid at the time of this writing of 95 cents.

CytomX Therapeutics Enters Oversold Territory (CTMX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

CytomX Announces Management Team Changes

Stocks Lower as Crude Slump Weighs on Energy Sector

Stocks Lower as Crude Slump Weighs on Energy Sector

Stocks snap a holding pattern to pull lower on Monday afternoon as a crude oil slump weighS on the energy sector.

Biotechs Remain the Best Place For Stock Picking

Biotechs Remain the Best Place For Stock Picking

Biotech companies show more energy than the rest of the market Monday.

Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference

Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference

Stocks move mostly higher on Monday morning as a hearing on Russia's involvement in the U.S. election begins on Capitol Hill.

Biotech Premarket Movers: CytomX, Aevi, Esperion

Biotech Premarket Movers: CytomX, Aevi, Esperion

CytomX Therapeutics, Aevi Genomic Medicine and Esperion Therapeutics were among the biotech stock movers in premarket trading on Monday.

CytomX Soars on Bristol-Myers Partnership

CytomX Soars on Bristol-Myers Partnership

Shares of the biotech, which researches cancer drugs, were up nearly 30% ahead of market's open.

Stock Futures Slip After G20 Meeting Raises Fears of Protectionism

Stock Futures Slip After G20 Meeting Raises Fears of Protectionism

Stock futures move mostly lower on Monday after the weekend's G20 meeting raises fears over protectionist attitudes among the world's largest economies.

CytomX Therapeutics Announces Teleconference And Webcast To Provide Corporate Update

Teleconference Scheduled for Monday, March 20, 2017 at 8:00 a.m. ET

CytomX Announces Selection By Bristol-Myers Squibb Of First Clinical Candidate Probody From Collaboration

CytomX Announces Selection By Bristol-Myers Squibb Of First Clinical Candidate Probody From Collaboration

CTLA-4 Probody Moves to IND-Enabling Studies

CytomX Announces Fourth Target Selection By Bristol-Myers Squibb Under Strategic Oncology Collaboration

CytomX Announces Fourth Target Selection By Bristol-Myers Squibb Under Strategic Oncology Collaboration

Triggers $15 Million Milestone Payment to CytomX

Relative Strength Alert For CytomX Therapeutics

Relative Strength Alert For CytomX Therapeutics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AER, AIMC, ALLY, BKU, PH, VSH Downgrades: CRAY, HMSY, OPK, SOHO, SONS, TRNC, TSRI, UTSI Initiations: CTMX, DERM Read on to get TheStreet Quant Ratings' detailed report: